Literature DB >> 34129793

Evolution of an asymptomatic first stage of infection in a heterogeneous population.

Chadi M Saad-Roy1, Bryan T Grenfell2,3, Simon A Levin2, P van den Driessche4, Ned S Wingreen5.   

Abstract

Pathogens evolve different life-history strategies, which depend in part on differences in their host populations. A central feature of hosts is their population structure (e.g. spatial). Additionally, hosts themselves can exhibit different degrees of symptoms when newly infected; this latency is a key life-history property of pathogens. With an evolutionary-epidemiological model, we examine the role of population structure on the evolutionary dynamics of latency. We focus on specific power-law-like formulations for transmission and progression from the first infectious stage as a function of latency, assuming that the across-group to within-group transmission ratio increases if hosts are less symptomatic. We find that simple population heterogeneity can lead to local evolutionarily stable strategies (ESSs) at zero and infinite latency in situations where a unique ESS exists in the corresponding homogeneous case. Furthermore, there can exist more than one interior evolutionarily singular strategy. We find that this diversity of outcomes is due to the (possibly slight) advantage of across-group transmission for pathogens that produce fewer symptoms in a first infectious stage. Thus, our work reveals that allowing individuals without symptoms to travel can have important unintended evolutionary effects and is thus fundamentally problematic in view of the evolutionary dynamics of latency.

Entities:  

Keywords:  asymptomatic infection stage; disease control; pathogen evolution; population heterogeneity

Mesh:

Year:  2021        PMID: 34129793      PMCID: PMC8205539          DOI: 10.1098/rsif.2021.0175

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.293


  35 in total

1.  Large shifts in pathogen virulence relate to host population structure.

Authors:  M Boots; P J Hudson; A Sasaki
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

2.  The effect of heterogeneity in measles vaccination on population immunity.

Authors:  K Glass; K Kappey; B T Grenfell
Journal:  Epidemiol Infect       Date:  2004-08       Impact factor: 2.451

3.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations.

Authors:  O Diekmann; J A Heesterbeek; J A Metz
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

4.  The geometric theory of adaptive evolution: trade-off and invasion plots.

Authors:  Roger G Bowers; Andrew Hoyle; Andrew White; Michael Boots
Journal:  J Theor Biol       Date:  2004-12-08       Impact factor: 2.691

5.  Adaptation and the evolution of parasite virulence in a connected world.

Authors:  Geoff Wild; Andy Gardner; Stuart A West
Journal:  Nature       Date:  2009-05-27       Impact factor: 49.962

6.  Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future.

Authors:  S Alizon; A Hurford; N Mideo; M Van Baalen
Journal:  J Evol Biol       Date:  2009-02       Impact factor: 2.411

7.  Spatial heterogeneity in epidemic models.

Authors:  A L Lloyd; R M May
Journal:  J Theor Biol       Date:  1996-03-07       Impact factor: 2.691

8.  Modeling the trade-off between transmissibility and contact in infectious disease dynamics.

Authors:  Chiu-Ju Lin; Kristen A Deger; Joseph H Tien
Journal:  Math Biosci       Date:  2016-04-19       Impact factor: 2.144

Review 9.  Spatial heterogeneity, nonlinear dynamics and chaos in infectious diseases.

Authors:  B T Grenfell; A Kleczkowski; C A Gilligan; B M Bolker
Journal:  Stat Methods Med Res       Date:  1995-06       Impact factor: 3.021

10.  Superinfection and the evolution of an initial asymptomatic stage.

Authors:  Chadi M Saad-Roy; Bryan T Grenfell; Simon A Levin; Lorenzo Pellis; Helena B Stage; P van den Driessche; Ned S Wingreen
Journal:  R Soc Open Sci       Date:  2021-01-27       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.